Interim Report First Half Year 2024, 1 January – 30 June 2024
Read the report PDF (in English) here
MEET US AT:
Meet us here
Meet us here
Meet us here
Meet us here
Meet us here
Meet us here
Meet us here
Meet us here
ARTICLES:
2. analyse – Pila Pharma Halvårsrapport 2024 (September 30, 2024)
Read the report PDF (in Danish) here
Read the report (in Swedish) here
Read the report PDF (in Danish) here
Read the report (in English) here
PRESENTATIONS AND INTERVIEWS:
PILA PHARMA STOKK.io After-Work Q&A [October 28, 2024]
PILA PHARMA’s CEO, Mr. Gustav H. Gram hosts an investor after-work Q&A specifically tailored with investor questions collected from different Stock trading forums and PILA PHARMA’s social media platforms.
In this session he answers questions from investors that touches upon the status, happenings and other things such as the market and global trends for Diabetes, Obesity and Cardiovascular disease, disease areas that PILA aims to address.
The Q&A was held together with moderator Anders Egsvang Rasmussen from Stokk.io, a platform that facilitates investor reach for companies.
The Q&A is conducted in English here